MicroRNA as a Diagnostic Tool, Therapeutic Target and Potential Biomarker in Cutaneous Malignant Melanoma Detection-Narrative Review

被引:14
作者
Poniewierska-Baran, Agata [1 ]
Zadroga, Lukasz [2 ]
Danilyan, Edo [3 ]
Malkowska, Paulina [4 ]
Niedzwiedzka-Rystwej, Paulina [1 ]
Pawlik, Andrzej [2 ]
机构
[1] Univ Szczecin, Inst Biol, Felczaka 3C, PL-71412 Szczecin, Poland
[2] Pomeranian Med Univ, Dept Physiol, Powstancow Wielkopolskich 72, PL-70111 Szczecin, Poland
[3] Inst Teknol Sepuluh Nopember, Fac Sci & Data Analyt, Biol Dept, Surabaya 60111, Indonesia
[4] Univ Szczecin, Doctoral Sch, PL-71412 Szczecin, Poland
关键词
miRNA; melanoma; biomarker; skin cancer; metastasis; clinical trials; CELL-CYCLE ARREST; UVEAL MELANOMA; EXPRESSION PROFILES; MIRNA EXPRESSION; PROGRESSION; GENE; IDENTIFICATION; PROLIFERATION; TRANSCRIPTION; PROGNOSIS;
D O I
10.3390/ijms24065386
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Melanoma is the most serious type of skin cancer, causing a large majority of deaths but accounting for only similar to 1% of all skin cancer cases. The worldwide incidence of malignant melanoma is increasing, causing a serious socio-economic problem. Melanoma is diagnosed mainly in young and middle-aged people, which distinguishes it from other solid tumors detected mainly in mature people. The early detection of cutaneous malignant melanoma (CMM) remains a priority and it is a key factor limiting mortality. Doctors and scientists around the world want to improve the quality of diagnosis and treatment, and are constantly looking for new, promising opportunities, including the use of microRNAs (miRNAs), to fight melanoma cancer. This article reviews miRNA as a potential biomarker and diagnostics tool as a therapeutic drugs in CMM treatment. We also present a review of the current clinical trials being carried out worldwide, in which miRNAs are a target for melanoma treatment.
引用
收藏
页数:25
相关论文
共 147 条
[1]   Potential Onco-Suppressive Role of miR122 and miR144 in Uveal Melanoma through ADAM10 and C-Met Inhibition [J].
Amaro, Adriana ;
Croce, Michela ;
Ferrini, Silvano ;
Barisione, Gaia ;
Gualco, Marina ;
Perri, Patrizia ;
Pfeffer, Ulrich ;
Jager, Martine J. ;
Coupland, Sarah E. ;
Mosci, Carlo ;
Filaci, Gilberto ;
Fabbi, Marina ;
Queirolo, Paola ;
Gangemi, Rosaria .
CANCERS, 2020, 12 (06) :1-16
[2]   microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis [J].
Annese, Tiziana ;
Tamma, Roberto ;
De Giorgis, Michelina ;
Ribatti, Domenico .
FRONTIERS IN ONCOLOGY, 2020, 10
[3]   Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma [J].
Armand-Labit, Virginie ;
Meyer, Nicolas ;
Casanova, Anne ;
Bonnabau, Henri ;
Platzer, Valerie ;
Tournier, Emilie ;
Sansas, Benoit ;
Verdun, Stephane ;
Thouvenot, Benoit ;
Hilselberger, Benoit ;
Doncescu, Andrei ;
Lamant, Laurence ;
Lacroix-Triki, Magali ;
Favre, Gilles ;
Pradines, Anne .
ACTA DERMATO-VENEREOLOGICA, 2016, 96 (01) :29-34
[4]   microRNA-155, Induced by Interleukin-1β, Represses the Expression of Microphthalmia-Associated Transcription Factor (MITF-M) in Melanoma Cells [J].
Arts, Nathalie ;
Cane, Stefania ;
Hennequart, Marc ;
Lamy, Juliette ;
Bommer, Guido ;
Van den Eynde, Benoit ;
De Plaen, Etienne .
PLOS ONE, 2015, 10 (04)
[5]   PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p [J].
Audrito, Valentina ;
Serra, Sara ;
Stingi, Aureliano ;
Orso, Francesca ;
Gaudino, Federica ;
Bologna, Cinzia ;
Neri, Francesco ;
Garaffo, Giulia ;
Nassini, Romina ;
Baroni, Gianna ;
Rulli, Eliana ;
Massi, Daniela ;
Oliviero, Salvatore ;
Piva, Roberto ;
Taverna, Daniela ;
Mandala, Mario ;
Deaglio, Silvia .
ONCOTARGET, 2017, 8 (09) :15894-15911
[6]   Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing [J].
Babapoor, Sankhiros ;
Wu, Rong ;
Kozubek, James ;
Auidi, Donna ;
Grant-Kels, Jane M. ;
Dadras, Soheil S. .
LABORATORY INVESTIGATION, 2017, 97 (06) :636-648
[7]   microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis [J].
Babapoor, Sankhiros ;
Horwich, Michael ;
Wu, Rong ;
Levinson, Shauna ;
Gandhi, Manoj ;
Makkar, Hanspaul ;
Kristjansson, Arni ;
Chang, Mary ;
Dadras, Soheil S. .
MODERN PATHOLOGY, 2016, 29 (05) :461-475
[8]   Chronic inflammation and cancer: suppressing the suppressors [J].
Baniyash, Michal ;
Sade-Feldman, Moshe ;
Kanterman, Julia .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (01) :11-20
[9]   Searching for the 'melano-miRs': miR-214 drives melanoma metastasis [J].
Bar-Eli, Menashe .
EMBO JOURNAL, 2011, 30 (10) :1880-1881
[10]   Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma [J].
Barbato, Anna ;
Iuliano, Antonella ;
Volpe, Mariagrazia ;
D'Alterio, Romina ;
Brillante, Simona ;
Massa, Filomena ;
De Cegli, Rossella ;
Carrella, Sabrina ;
Salati, Massimiliano ;
Russo, Annapina ;
Russo, Giulia ;
Riccardo, Sara ;
Cacchiarelli, Davide ;
Capone, Mariaelena ;
Madonna, Gabriele ;
Ascierto, Paolo A. ;
Franco, Brunella ;
Indrieri, Alessia ;
Carotenuto, Pietro .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) :1-27